DCM
LGND icon

Driehaus Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Driehaus Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.6M Sell
118,169
-4,157
-3% -$822K 0.17% 179
2025
Q4 		$23.1M Sell
122,326
-40,475
-25% -$7.78M 0.16% 188
2025
Q3 		$28.8M Buy
162,801
+1,639
+1% +$244K 0.21% 159
2025
Q2 		$18.3M Sell
161,162
-1,008
-0.6% -$108K 0.15% 189
2025
Q1 		$17.1M Sell
162,170
-601
-0.4% -$68K 0.16% 183
2024
Q4 		$17.4M Buy
162,771
+67,033
+70% +$7.58M 0.14% 185
2024
Q3 		$9.58M Buy
+95,738
New +$9.64M 0.08% 234
2018
Q4 		– Sell
-25,462
Closed -$4.36M – 468
2018
Q3 		$4.36M Buy
+25,462
New +$3.84M 0.13% 199
2016
Q3 		– Sell
-26,485
Closed -$1.97M – 567
2016
Q2 		$1.97M Sell
26,485
-10,158
-28% -$754K 0.07% 268
2016
Q1 		$2.45M Buy
36,643
+8,900
+32% +$541K 0.08% 254
2015
Q4 		$1.88M Buy
+27,743
New +$1.71M 0.06% 307
2014
Q3 		– Sell
-244,826
Closed -$9.51M – 579
2014
Q2 		$9.51M Buy
244,826
+28,014
+13% +$1.14M 0.31% 74
2014
Q1 		$9.1M Buy
216,812
+15,555
+8% +$648K 0.29% 84
2013
Q4 		$6.6M Buy
+201,257
New +$6.56M 0.24% 131
2013
Q3 		– Sell
-31,831
Closed -$743K – 483
2013
Q2 		$743K Buy
+31,831
New +$572K 0.03% 366

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Driehaus Capital Management's LGND Position: Q1 2026 in Review

Driehaus Capital Management reduced its Ligand Pharmaceuticals (LGND) stake by 3.4% in Q1 2026, selling an estimated $822K and leaving 118,169 shares worth $23.6M. The position accounts for 0.17% of the portfolio, ranked #179.

Driehaus Capital Management first reported a position in LGND in Q2 2013 and has held it in 15 quarters since. The position peaked at $28.8M in Q3 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Driehaus Capital Management held 118,169 shares of Ligand Pharmaceuticals worth $23.6M as of Q1 2026.
  • Driehaus Capital Management sold 4,157 Ligand Pharmaceuticals shares in Q1 2026, an estimated $822K.
  • Ligand Pharmaceuticals made up 0.17% of Driehaus Capital Management's portfolio in Q1 2026, its #179 holding.
  • Driehaus Capital Management first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • Driehaus Capital Management's Ligand Pharmaceuticals position peaked at $28.8M in Q3 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.